Back to Stakeholders
Categories

1 domain / 2 areas / 1 specialization

Aja Ventures

Data updated

Vancouver, British Columbia, Canada

Aja Ventures is a Canadian investment company associated with venture investing in plant medicine, technology, and wellness, with a stated emphasis on early-stage ventures developing psychedelic medicine. Public-facing profiles also describe it as a venture capital fund or investment company connected to psychedelic-adjacent healthcare and longevity themes.

It matters in the psychedelic ecosystem because its stated strategy includes backing early-stage psychedelic therapy and drug-discovery efforts, alongside related areas like genetic testing, functional medicine, and personalized healthcare. Public profile sources also point to investments or strategic exposure in companies tied to natural psychedelic medicines and plant-based wellness.

Investor Context

Venture Capital

Investment Context

This stakeholder is listed as a Venture Capital Fund within Venture Capital. Its public geography context is global. Public stage signals include Seed, Series A/B, and Growth / Late Stage. Public focus areas include Drug Development.

Public Portfolio Examples

  • Filament VenturesRecorded investment
  • Cellular GoodsSeed - undisclosed - Mar 1, 2021

Aja Ventures presents itself as an investor at the intersection of plant medicine, technology, and wellness, with a portfolio thesis centered on early-stage psychedelic medicine, personalized healthcare, and adjacent enabling technologies. Public materials describe a strategy that includes supporting psychedelic therapy, drug discovery, and related platforms such as genomics, precision medicine, and wearable technology. The firm is also linked to Canadian corporate records and a Vancouver office, which supports a Canada-based profile for Blossom.

Investor Type

Venture Capital Fund

Geographic Scope

Global

Psychedelic Focus

Psychedelic-Adjacent Focus

Engagement

Active

Investment Stage Focus

SeedSeries A/BGrowth / Late Stage

Investment Focus Areas

Drug Development

Investment Orientation

Engagement Status

Active

Investor Type

Venture Capital Fund

Investment Website

Recorded Investments

Filament Ventures

Date unknown

Publicly described as a drug discovery and extraction technology company focused on naturally derived psychedelic medicines.

Aja Ventures | Psychedelic Finance

Cellular Goods

Mar 1, 2021

Seed - undisclosed

Publicly described as a seed investment in a consumer plant-based wellness company with CBD and plant medicine exposure.

Aja Ventures | Psychedelic Finance

Quick Facts

Founded
2020
HQ
Vancouver, British Columbia, Canada
Website
Visit